Core F The overall goals of the Imaging Core are to obtain the highest caliber structural and functional imaging data on ADRC participants; to make these data available to a wide spectrum of investigators at Stanford; and to make the Alzheimer's Disease Neuroimaging Initiative (ADNI) data more accessible to investigators from non- imaging backgrounds. The Imaging Core, capitalizing on Stanford's strength in imaging brain networks, will focus on measures of functional and structural connectivity. Dr. Glover and Dr. Bammer, Core Co- Investigators, have made critical contributions to the acquisition and analysis of resting-state fMRI and diffusion-weighted imaging, respectively. Dr. Greicius, the Core Director, has made important advances in the application of functional connectivity measures to the study of Alzheimer's disease. A second major focus of the Imaging Core will be to make the acquired data available to and readily used by researchers across disciplines and schools at Stanford. To this end, the Imaging Core will take advantage of the neurobiological imaging management system (NIMS) built by Dr. Dougherty, the third Core Co-Investigator. NIMS has been in place for more than two years and provides a user-friendly interface for investigators to download brain imaging, and related, data. The Imaging Core will use the NIMS infrastructure to provide researchers with subject imaging data in three stages of processing: raw, processed, and abstracted summary measures. The imaging data will be linked to subjects' ancillary data (including neuropsychological measures, spinal fluid proteins, plasma proteomics, etc.) This will allow the widest possible set of Stanford investigators, with or without imaging expertise, to test hypotheses using the ADRC data. In parallel with the imaging data acquired through the ADRC, the Imaging Core will provide investigators across the Stanford campus with a curated, turnkey version of the ADNI dataset. Dr. Greicius' imaging group has extensive experience with the ADNI dataset and has developed a pipeline for quality control and data processing. The ADNI imaging data and associated ancillary data such as spinal fluid proteins, genotypes, etc. will also be available on NIMS. As with the ADRC data, this should greatly amplify the number of researchers who can benefit from the incredibly rich, multimodal ADNI data.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
1P50AG047366-01A1
Application #
8849316
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2015-07-01
Budget End
2016-04-30
Support Year
1
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Kim, Jeehyun; Zhang, Kai; Cai, Weidong et al. (2018) Dopamine-related dissociation of cortical and subcortical brain activations in cognitively unimpaired Parkinson's disease patients OFF and ON medications. Neuropsychologia 119:24-33
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Smith, Alexander K; Periyakoil, Vyjeyanthi S (2018) Should We Bury ""The Good Death""? J Am Geriatr Soc 66:856-858
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25

Showing the most recent 10 out of 117 publications